Author Archives: Lu Rahman

#Assay development optimisation & technology #Online focus

Extending sensitivity of biomarker quantitation immunoassays

Patricia Ahrweiler, Field Marketing Manager, Gyros Protein Technologies explains how its Gyrolab Bioaffy 4000 CD extends Gyrolab assay sensitivity to the low picogram level for improved analysis of biomarkers Biomarker research has accelerated in recent years, driving the development of novel biomarker candidates and panels for the study of a range… Read More

#Exclusive Content #News

#Clinical trials #Covid-19 #Immunology / Virology & Vaccines

COVID-19 vaccine pill a possibility?

Professor Sarah Gilbert, head of the team behind the Oxford AstraZeneca COVID-19 vaccine, has told UK MPs that there is a possibility the vaccine could be taken orally and perhaps also via a nasal spray. Reported in The Guardian newspaper today, she was asked by MP Graham Stringer how the… Read More

#Covid-19 #Editor's Choice #News #Trending News

#Genetics / genomes #Genome sequencing

Middle East genome-wide study reveals Arab genetic risk factors

A group of researchers at Qatar Foundation have reported the first and largest genetic association study in the Middle East, that has been published online in Nature Communications. The study titled Whole genome sequencing in the Middle Eastern Qatari population identifies genetic associations with 45 clinically relevant traits highlights a vital… Read More

#Editor's Choice #News

#Drug discovery #Events

Research & Innovation 2021 virtual

ELRIG’s virtual event  will take place on 23 and 24 February and will cover therapeutic innovation for the new decade. Research and Innovation 2021 will delve into the following four key scientific areas: Innovations in structural biology & biophysics; The rise of immunology across drug discovery; Seeking novel drug targets for the discovery… Read More

#News

#ATMP #Cell and gene therapy #Cell and Gene Therapy Catapult #Clinical trials

Report cites UK as internationally attractive for development of cell and gene therapies

The Cell and Gene Therapy Catapult (CGT Catapult) has published today the 2020 Advanced Therapy Medicinal Product (ATMP) clinical trials database and report, which show a marked 20% growth in the number of ATMP clinical trials across the UK. The number of commercially sponsored trials has shown a dramatic surge… Read More

#Editor's Choice #News

#Biotechnology #Drug development #Drug discovery

Quotient Sciences CEO talks acquisitions, efficiency and finding cures fast

Mark Egerton, Chief Executive Officer, Quotient Sciences, spoke to Lu Rahman about the company’s acquisition of Arcinova and what it means for the drug discovery sector. Quotient Sciences, the drug development and manufacturing accelerator, recently acquired Arcinova, the UK-based multiservice contract development and manufacturing organisation (CDMO). Boasting over 40 years of… Read More

#Editor's Choice #News #Trending News

#Biotechnology #CRISPR #Genomics

ERS Genomics and G+FLAS Life Sciences sign CRISPR/Cas9 license agreement

ERS Genomics and G+FLAS Life Sciences, a biotechnology company developing research tools and reagents associated with CRISPR technology, have announced a non-exclusive license agreement granting G+FLAS access to ERS Genomics’ CRISPR/Cas9 patent portfolio. G+FLAS supports research organisations by providing CRISPR-related biological research services, tools, and reagents. The Ccampany produces all… Read More

#News

#Life sciences #Regulatory

EMA sets clock ticking for life sciences companies to get their data in order

The European Medicines Agency (EMA) has published IDMP data standards that will drive change and innovation in the life sciences sector. Remco Munnik, Associate Director at Life Sciences consultancy, Iperion, has been working with the group creating the EU IDMP Implementation Guide version 2.0 (EU IG). Iperion will revealthe implications… Read More

#Editor's Choice #News #Regulatory

#Covid-19 #Immunology / Virology & Vaccines

Pfizer and AstraZeneca COVID-19 vaccine working, suggests Scottish study

The study is the first to describe across an entire country the effect of the Pfizer and Oxford-AstraZeneca jabs in the community on preventing severe illness resulting in hospitalisation. Previous results about vaccine efficacy have come from clinical trials. Hospitalisation drop By the fourth week after receiving the initial dose,… Read More

#Covid-19 #Editor's Choice #News #Trending News

#Clinical trials #Covid-19 #Immunology / Virology & Vaccines

Sanofi and GSK start new Phase II study of their COVID-19 vaccine candidate

Sanofi and GlaxoSmithKline (GSK) have begun a new Phase II study with 720 volunteers aged 18 and over to select the most appropriate antigen dosage for Phase III evaluation of their adjuvanted recombinant protein COVID-19 vaccine candidate. “Over the past few weeks, our teams have worked to refine the antigen… Read More

#Covid-19 #Editor's Choice #News #Trending News

#Life sciences #Pharmaceuticals #Research & development

Pistoia Alliance Conference: Collaborative R&D in Action

The Pistoia Alliance will be holding a free virtual conference which will include a series of  discussions with top pharma R&D leaders on the big issues facing our industry. Collaborative R&D in Action, April 20-21 & 23, provides a platform for R&D stakeholders to collaborate, learn and network across the… Read More

#Editor's Choice #News

#Biotechnology #Clinical trials #Drug development #Pharmaceutical

New psychedelic medicine COO looks to boost pharma and biotech collaborations

Beckley Psytech, a company dedicated to addressing neurological and psychiatric disorders through psychedelic medicine, has appointed Andy Page as its Chief Operating Officer. Page brings over 25 years’ experience working within global pharmaceutical and medtech organisations in strategic and operation roles. He started his career at SmithKline Beecham before joining… Read More

#Editor's Choice #News

#Clinical trials #Therapeutics

Clinical trial shows potential of MDMA therapy for addiction

Awakn Life Sciences has published results from its CMO Dr Ben Sessa’s Bristol Imperial MDMA in Alcoholism (BIMA) trial, an open-label safety, tolerability and proof-of-concept study investigating the potential role for MDMA therapy in treating patients with alcohol use disorder (AUD). Results published in the Journal of Psychopharmacology, show that… Read More

#Editor's Choice #News

#Cell painting #Cellular imaging #High Content Screening #Reagents

PerkinElmer launches first cell painting kit

PerkinElmer has launched the first cell painting kit as part of its new portfolio of PhenoVue cellular imaging reagents. This new range of reagents leverages PerkinElmer’s expertise in cellular imaging and high-content screening and works alongside its microplates, automation, software and high-content screening instruments. With this entire screening workflow, researchers… Read More

#News

#Events #Specialty chemicals

Chemspec Europe 2021 postponed

The 35th international exhibition for fine and speciality chemicals will now take place as live and digital hybrid event from 29-30 September 2021. Mack-Brooks Exhibitions has announced the postponement of Chemspec Europe 2021, which was scheduled to take place at Messe Frankfurt in Germany from 19 to 20 May 2021. Read More

#Editor's Choice #News

#AI / data analytics / healthtech / informatics #Cell therapy #Cold chain

Cytiva and Brooks Life Sciences enhance automation in cold chain solutions

Cytiva and Brooks Life Sciences, a division of Brooks Automation, are working together to expand Cytiva’s Chronicle software capabilities to integrate Brooks Life Sciences BioStore III automated storage platform. This has been purpose built to handle a range of high value materials between the temperatures of -20°C and -190°C in… Read More

#News